Association between polymyalgia rheumatica and vascular disease: A systematic review

Arthritis Care and Research

Volumn 64, Issue 9, 2012, Pages 1301-1305

  Hancock, Adam T ^a   Mallen, Christian D ^a   Belcher, John ^a   Hider, Samantha L ^a  

^a KEELE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CAUSE OF DEATH; CINAHL; COCHRANE LIBRARY; COMORBIDITY; DIABETES MELLITUS; DISEASE ASSOCIATION; EMBASE; GIANT CELL ARTERITIS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MEDLINE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR DISEASE; RETROSPECTIVE STUDY; RHEUMATIC POLYMYALGIA; RISK FACTOR; SYSTEMATIC REVIEW; VASCULAR DISEASE; VERTEBRAL ARTERY STENOSIS;

FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMYALGIA RHEUMATICA; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; VASCULAR DISEASES;

EID: 84865587975     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.21712     Document Type: Article

References (21)

1. Smeeth L, Cook C, Hall AJ,. Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001. Ann Rheum Dis 2006; 65: 1093-8.
2. Michet CJ, Matteson EL,. Polymyalgia rheumatica. BMJ 2008; 336: 765-9.
3. Hernandez-Rodriguez J, Cid MC, Lopez-Soto A, Espigol-Frigole G, Bosch X,. Treatment of polymyalgia rheumatica: a systematic review. Arch Intern Med 2009; 169: 1839-50.
4. Kuo CF, See LC, Luo SF, Ko YS, Lin YS, Hwang JS, et al. Gout: an independent risk factor for all-cause and cardiovascular mortality. Rheumatology (Oxford) 2010; 49: 141-6.
5. Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D,. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 2008; 59: 1690-7.
6. Hak AE, Karlson EW, Feskanich D, Stampfer MJ, Costenbader KH,. Systemic lupus erythematosus and the risk of cardiovascular disease: results from the Nurses' Health Study. Arthritis Rheum 2009; 61: 1396-402.
7. Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM,. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J 2010; 31: 1000-6.
8. Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010; 69: 325-31.
9. Camellino D, Cimmino MA,. Imaging of polymyalgia rheumatica: indications on its pathogenesis, diagnosis and prognosis. Rheumatology (Oxford) 2012; 51: 77-86.
10. Gabriel SE, Sunku J, Salvarani C, O'Fallon WM, Hunder GG,. Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica. Arthritis Rheum 1997; 40: 1873-8.
11. Kremers HM, Reinalda MS, Crowson CS, Davis JM III, Hunder GG, Gabriel SE,. Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica. Arthritis Rheum 2007; 57: 279-86.
12. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2010. URL: http://www.ohri.ca/programs/clinical-epidemiology/ oxford.asp.
13. Altman DG,. Systematic reviews of evaluations of prognostic variables. BMJ 2001; 323: 224-8.
14. Bengtsson BA, Malmvall BE,. Prognosis of giant cell arteritis including temporal arteritis and polymyalgia rheumatica: a follow-up study on ninety patients treated with corticosteroids. Acta Med Scand 1981; 209: 337-45.
15. Andersson R, Malmvall BE, Bengtsson BA,. Long-term survival in giant cell arteritis including temporal arteritis and polymyalgia rheumatica: a follow-up study of 90 patients treated with corticosteroids. Acta Med Scand 1986; 220: 361-4.
16. Schaufelberger C, Bengtsson BA, Andersson R,. Epidemiology and mortality in 220 patients with polymyalgia rheumatica. Br J Rheumatol 1995; 34: 261-4.
17. Uddhammar A, Eriksson A, Nystrom L, Stenling R, Rantapaa-Dahlqvist S,. Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden. J Rheumatol 2002; 29: 737-42.
18. Myklebust G, Wilsgaard T, Jacobsen BK, Gran JT,. Causes of death in polymyalgia rheumatica: a prospective longitudinal study of 315 cases and matched population controls. Scand J Rheumatol 2003; 32: 38-41.
19. Kremers HM, Reinalda MS, Crowson CS, Zinsmeister AR, Hunder GG, Gabriel SE,. Direct medical costs of polymyalgia rheumatica. Arthritis Rheum 2005; 53: 578-84.
20. Warrington KJ, Jarpa EP, Crowson CS, Cooper LT, Hunder GG, Matteson EL, et al. Increased risk of peripheral arterial disease in polymyalgia rheumatica: a population-based cohort study. Arthritis Res Ther 2009; 11: R50.
21. Pfadenhauer K, Esser M, Berger K,. Vertebrobasilar ischemia and structural abnormalities of the vertebral arteries in active temporal arteritis and polymyalgia rheumatica: an ultrasonographic case-control study. J Rheumatol 2005; 32: 2356-60.